Novolog Overview

  • Year Founded
  • 1966

Year Founded

  • Status
  • Public

  • Employees
  • 916

Employees

  • Stock Symbol
  • NVLG

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $0.24
  • (As of Friday Closing)

Novolog General Information

Description

Novolog (pharm-up 1966) Ltd is an Israeli public health care company. The company operates in four divisions: The digital division, Health Division, The logistics division and International health services.

Contact Information

Website
www.novolog.co.il
Formerly Known As
Pharm-Abi, Pharm-up
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 55 Hamayan street
  • Modiin 7171301
  • Israel
+972
Primary Industry
Distributors (Healthcare)
Other Industries
Logistics
Stock Exchange
TAE
Vertical(s)
Industrials
Corporate Office
  • 55 Hamayan street
  • Modiin 7171301
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novolog Stock Performance

As of 13-Nov-2026, Novolog’s stock price is $0.24. Its current market cap is $121M with 511M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.24 $0.22 - $0.42 $121M 511M 611K

Novolog Financials Summary

As of 30-Jun-2026, Novolog has a trailing 12-month revenue of $570M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 135,522 201,705 247,400 189,676
Revenue 569,850 519,609 542,124 443,594
EBITDA 30,832 30,309 36,603 31,881
Net Income (212) 1,184 10,603 (11,337)
Total Assets 905,685 675,799 831,431 734,550
Total Debt 57,286 57,647 54,334 56,682
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novolog Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novolog‘s full profile, request access.

Request a free trial

Novolog Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Novolog Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2171577-A1 System and method for automatically generating a software application Inactive 22-Jun-2007

Novolog Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novolog Investments & Acquisitions (10)

Novolog’s most recent deal was a Merger/Acquisition with Pronto Diagnostics for . The deal was made on 19-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pronto Diagnostics 19-Feb-2023 Merger/Acquisition Distributors/Wholesale
Gsap Biomed 17-Jul-2022 Merger/Acquisition Consulting Services (B2B)
E.Y.A. Medical (Ein-Tal) 12-May-2022 Merger/Acquisition Clinics/Outpatient Services
Medflex 11-Mar-2021 Early Stage VC Enterprise Systems (Healthcare)
American Medical Laboratories (Laboratory Services (Healthcare)) 03-Mar-2021 Merger/Acquisition Laboratory Services (Healthcare)
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Novolog ESG

Risk Overview

Risk Rating

Updated April, 30, 2022

20.85 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,708

Rank

Percentile

Healthcare

Industry

of 625

Rank

Percentile

Medical Distribution

Subindustry

of 47

Rank

Percentile

To view Novolog’s complete esg history, request access »

Novolog Exits (2)

Novolog’s most recent exit was on 04-Sep-2019 from Odoro. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Odoro 04-Sep-2019 Completed
Well-Beat 01-Aug-2018 Seed Round Completed
  • 2 buyers
To view Novolog’s complete exits history, request access »

Novolog Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Infomed Digital Health Tel Aviv, Israel 2018
Target Care Health Services Ashdod, Israel 2017
Gsap Biomed Haifa, Israel 2009
Pronto Diagnostics Tel Aviv, Israel 2003
E.Y.A. Medical (Ein-Tal) Tel Aviv, Israel 1984
You’re viewing 5 of 6 affiliates. Get the full list.  »

Novolog FAQs

  • When was Novolog founded?

    Novolog was founded in 1966.

  • Where is Novolog headquartered?

    Novolog is headquartered in Modiin, Israel.

  • What is the size of Novolog?

    Novolog has 916 total employees.

  • What industry is Novolog in?

    Novolog’s primary industry is Distributors (Healthcare).

  • Is Novolog a private or public company?

    Novolog is a Public company.

  • What is Novolog’s stock symbol?

    The ticker symbol for Novolog is NVLG.

  • What is the current stock price of Novolog?

    As of 13-Nov-2026 the stock price of Novolog is $0.24.

  • What is the current market cap of Novolog?

    The current market capitalization of Novolog is $121M.

  • What is Novolog’s current revenue?

    The trailing twelve month revenue for Novolog is $570M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process